Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ries

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Orphanet Journal of Rare Diseases|April 22, 2015
Pressure for drug development in lysosomal storage disorders - a quantitative analysis thirty years beyond the US orphan drug actKonstantin Mechler, William K Mountford, Georg F Hoffmann, et al.
Pharmacoeconomics|March 6, 2007
Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson diseaseDavid F Moore, Markus Ries, Evelyn L Forget, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 13, 2015
Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiencyKonstantin Mechler, William K Mountford, Georg F Hoffmann, et al.
Onkologie|March 15, 2013
Single-source tumor documentation - reusing oncology data for different purposesMarkus Ries, Hans-Ulrich Prokosch, Matthias W Beckmann, et al.
International Journal of Methods in Psychiatric Research|November 19, 2016
Defining the hidden evidence in autism research. Forty per cent of rigorously designed clinical trials remain unpublished - a cross-sectional analysisKonstantin Mechler, Georg F Hoffmann, Ralf W Dittmann, et al.
Plos One|August 25, 2016
Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional AnalysisJan Henje Döring, Anette Lampert, Georg F Hoffmann, et al.
Journal of Inherited Metabolic Disease|April 23, 2015
A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry diseaseRaphael Schiffmann, Caren Swift, Xuan Wang, et al.
Plos One|December 20, 2016
An Assessment of Publication Status of Pediatric Liver Transplantation StudiesThomas Breil, Daniel Wenning, Ulrike Teufel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 11, 2018
Corrigendum: Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysisMatthias Zielonka, Sven F Garbade, Stefan Kölker, et al.
BMJ Open|June 16, 2021
Patterns of extreme temperature-related catastrophic events in Europe including the Russian Federation: a cross-sectional analysis of the Emergency Events DatabaseHeiko Brennenstuhl, Manuel Will, Elias Ries, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Orphanet Journal of Rare Diseases|April 22, 2015
Pressure for drug development in lysosomal storage disorders - a quantitative analysis thirty years beyond the US orphan drug actKonstantin Mechler, William K Mountford, Georg F Hoffmann, et al.
Pharmacoeconomics|March 6, 2007
Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson diseaseDavid F Moore, Markus Ries, Evelyn L Forget, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 13, 2015
Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiencyKonstantin Mechler, William K Mountford, Georg F Hoffmann, et al.
Onkologie|March 15, 2013
Single-source tumor documentation - reusing oncology data for different purposesMarkus Ries, Hans-Ulrich Prokosch, Matthias W Beckmann, et al.
International Journal of Methods in Psychiatric Research|November 19, 2016
Defining the hidden evidence in autism research. Forty per cent of rigorously designed clinical trials remain unpublished - a cross-sectional analysisKonstantin Mechler, Georg F Hoffmann, Ralf W Dittmann, et al.
Plos One|August 25, 2016
Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional AnalysisJan Henje Döring, Anette Lampert, Georg F Hoffmann, et al.
Journal of Inherited Metabolic Disease|April 23, 2015
A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry diseaseRaphael Schiffmann, Caren Swift, Xuan Wang, et al.
Plos One|December 20, 2016
An Assessment of Publication Status of Pediatric Liver Transplantation StudiesThomas Breil, Daniel Wenning, Ulrike Teufel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 11, 2018
Corrigendum: Quantitative clinical characteristics of 53 patients with MPS VII: a cross-sectional analysisMatthias Zielonka, Sven F Garbade, Stefan Kölker, et al.
BMJ Open|June 16, 2021
Patterns of extreme temperature-related catastrophic events in Europe including the Russian Federation: a cross-sectional analysis of the Emergency Events DatabaseHeiko Brennenstuhl, Manuel Will, Elias Ries, et al.
Pageof 10